A novel µ‐conopeptide, CnIIIC, exerts potent and preferential inhibition of NaV1.2/1.4 channels and blocks neuronal nicotinic acetylcholine receptors

BACKGROUND AND PURPOSE The µ‐conopeptide family is defined by its ability to block voltage‐gated sodium channels (VGSCs), a property that can be used for the development of myorelaxants and analgesics. We characterized the pharmacology of a new µ‐conopeptide (µ‐CnIIIC) on a range of preparations and...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:British journal of pharmacology 2012-07, Vol.166 (5), p.1654-1668
Hauptverfasser: Favreau, Philippe, Benoit, Evelyne, Hocking, Henry G, Carlier, Ludovic, D' hoedt, Dieter, Leipold, Enrico, Markgraf, René, Schlumberger, Sébastien, Córdova, Marco A, Gaertner, Hubert, Paolini‐Bertrand, Marianne, Hartley, Oliver, Tytgat, Jan, Heinemann, Stefan H, Bertrand, Daniel, Boelens, Rolf, Stöcklin, Reto, Molgó, Jordi
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!